Site Map

Quantitative Bence-Jones protein test

Immunoglobulin light chains - urine; Urine Bence-Jones protein

This test measures the level of abnormal proteins called Bence-Jones proteins in the urine.

Images

How the Test is Performed

A clean-catch urine sample is needed. The clean-catch method is used to prevent germs from the penis or vagina from getting into a urine sample. To collect your urine, your health care provider may give you a special clean-catch kit that contains a cleansing solution and sterile wipes. Follow instructions exactly so that the results are accurate.

The sample is sent to the lab. There are many methods used to detect Bence-Jones proteins. One method, called immunoelectrophoresis, is the most accurate.

How the Test will Feel

The test involves only normal urination, and there is no discomfort.

Why the Test is Performed

Bence-Jones proteins are a part of regular antibodies called light chains. These proteins are not normally in urine. Sometimes, when your body makes too many antibodies, the level of light chains also rises. Bence-Jones proteins are small enough to be filtered out by the kidneys. The proteins then spill into the urine.

Your provider may order this test:

• To diagnose conditions that lead to protein in the urine
• If you have a lot of protein in your urine
• If you have signs of a blood cancer called multiple myeloma

Normal Results

A normal result means no Bence-Jones proteins are found in your urine.

What Abnormal Results Mean

Bence-Jones proteins are rarely found in urine. If they are, it is usually associated with multiple myeloma.

An abnormal result may also be due to:

• An abnormal buildup of proteins in tissues and organs (amyloidosis)
• Blood cancer called chronic lymphocytic leukemia
• Lymph system cancer (lymphoma)
• Buildup in the blood of a protein called M-protein (monoclonal gammopathy of unknown significance; MGUS)
• Chronic renal failure

Risks

There are no risks with this test.

Related Information

Antibody
Waldenstrom macroglobulinemia
Chronic lymphocytic leukemia (CLL)
Primary amyloidosis

References

Gertz MA, Dispenzieri A. Amyloidosis. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 174.

Rajkumar SV, Dispenzieri A. Multiple myeloma and related disorders. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 101. 

Riley RS, McPherson RA. Basic examination of urine. In: McPherson RA, Pincus MR, eds. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Philadelphia, PA: Elsevier; 2022:chap 29.

BACK TO TOP

Review Date: 6/17/2024  

Reviewed By: Todd Gersten, MD, Hematology/Oncology, Florida Cancer Specialists & Research Institute, Wellington, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

Health Content Provider 06/01/2025

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complied with the HONcode standard for trustworthy health information from 1995 to 2022, after which HON (Health On the Net, a not-for-profit organization that promoted transparent and reliable health information online) was discontinued.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2025 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.